Publications by authors named "Hugo Ferrari"
Article Synopsis
- Lung cancer is a leading cause of cancer-related deaths, necessitating advanced preclinical models to explore new treatments based on tumor genetics.
- Researchers developed and characterized cell lines and mouse models for non-small cell lung cancer (NSCLC) to monitor tumor growth and treatment response effectively.
- The study found that combining osimertinib and bevacizumab improves treatment outcomes for EGFR-mutated tumors, while adding afatinib helps inhibit tumor growth during treatment resistance, demonstrating the models’ utility for testing new therapies and understanding resistance mechanisms.
